Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR202102867544936
PACTR202102867544936
Recruiting
未知

Endothelial Dysfunction during The COVID-19 follow-up: TUN-EndCOV study

Not provided0 sites600 target enrollmentFebruary 3, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCirculatory SystemRespiratoryCardiology

Overview

Phase
未知
Intervention
Not specified
Conditions
Circulatory System
Sponsor
Not provided
Enrollment
600
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Not provided

Eligibility Criteria

Inclusion Criteria

  • •age \>18 years, both sexes;
  • •written informed consent;
  • •a recent diagnosis of COVID19 (1 \- 6 months) proven by RT\-PCR or viral rapid test.

Exclusion Criteria

  • •Age \<18 years
  • •Inability to express consent of the study
  • •Diseases carrying out a life \-expectancy \<1 year according to clinical judgment
  • •Pregnancy and breastfeeding
  • •Foreseen inability to attend scheduled visits

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Managing Endothelial Dysfunction in COVID-19: A Randomized Clinical Trial at the Lebanese American University Medical Center- Rizk HospitalCOVID-19 and the cardiovascular systemWe will aim at treating endothelial dysfunction caused by covid -19 virus by an endothelial protocol to try to improve the patient's outcomeCOVID-19T51.2
LBCTR2021014651AUMCRH80
Unknown
Phase 3
Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMCCovid19
NCT04631536Lebanese American University Medical Center42
Active, not recruiting
Phase 1
A prospective, randomised, placebo-controlled, investigator-initiated study of the effect of Sulodexide on endothelial protection in convalescent COVID-19 patients.
EUCTR2022-001958-36-HUCorporativo de Servicios Médicos Especializados S.A de C.V V (Centro Médico del Noroeste)200
Unknown
Phase 3
Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRHCovid19Endothelial Dysfunction
NCT04813471Lebanese American University Medical Center70
Completed
Not Applicable
Effect of COVID-19 on Endothelial FunctionCOVID-19Endothelial Dysfunction
NCT05500560University Hospital of Patras44